Ok, today I tried to do a Spreecast, which is essentially a platform that allows up to four people on screen at once with thousands of viewers watching live. It’s still very glitchy as you can see, but the concept is great! I was joined by Darshan Kulkarni who enters around the 20 min mark if youd like to fast forward, and ws also attempted to be joined by Pat Stone who will actually appear on a future spreecast. All glitches aside, Darshan got down to business and explained how CRO’s are becoming very big players in the industry, and we dabble into double billing in clinical trials as well. Hope you enjoy, and we will do more Spreecasts in the future as their platform improves.
So as I’ve been searching for good clinical trial, study participant focused websites over the years, you can say that I’ve been easily disappointed. I even tried to search for good content for Investigators and study coordinators but had trouble finding very many sources. This is one of the biggest reasons why I even created this website. This being said, ClinicalResearch.com , the study information website aimed first at study participants, is indeed a step in the right direction. What’s even more impressive is that the website is owned and operated by Quintiles, which in my opinion, is easily the industry leading CRO both in terms of market share and staying ahead of the curve. The website is not without it’s flaws, but it shows that even the CRO’s in our slow to adapt industry, are catching on to the idea of marketing your business around content. In this video I share ways in which the website could be even better, and what I like about it so far. If anyone from Quintiles is reading this, I’d love to work with you guys on this project or just sit down and talk about some good ideas! By the way, if you’d like to follow Quintiles on Twitter, here is the link.
In today’s interview, I turn to trusted Clinical Trials Guru regular guest Darshan Kulkarni. Ive been getting so many questions from research clinics asking me about my thoughts on ObamaCare and clinical trials, specifically, how will it affect our industry. In this video, Darshan and I explore this topic and discuss so many interesting angles such as biosimilars, innovations, etc. Let me know what you think about Obamacare. I’m waiting to hear from all of you!
So I was going to do a Hollywood Squares type interview with myself and 3 other clinical trial professionals from India, but due to my lack of knowledge regarding Indian Standard Time, I showed up an hour and a half too early! Still, I was lucky enough to have Shilpa Garg of SenseCR join me. Shilpa is CEO of her own company in the clinical trials space in India and we were able to discuss a few important issues regarding clinical trials and India such as ethics, taking advantage of the poor population, informed consent and more. Looking forward to Shilpa helping me set up a Spreecast with more researchers from India soon! Thanks.